584 related articles for article (PubMed ID: 2822101)
41. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2).
Arrol S; Mackness MI; Durrington PN
Atherosclerosis; 2000 Jun; 150(2):255-64. PubMed ID: 10856517
[TBL] [Abstract][Full Text] [Related]
42. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
43. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.
Rapp JH; Lespine A; Hamilton RL; Colyvas N; Chaumeton AH; Tweedie-Hardman J; Kotite L; Kunitake ST; Havel RJ; Kane JP
Arterioscler Thromb; 1994 Nov; 14(11):1767-74. PubMed ID: 7947602
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of the microsomal triglyceride transfer protein blocks the first step of apolipoprotein B lipoprotein assembly but not the addition of bulk core lipids in the second step.
Gordon DA; Jamil H; Gregg RE; Olofsson SO; Borén J
J Biol Chem; 1996 Dec; 271(51):33047-53. PubMed ID: 8955151
[TBL] [Abstract][Full Text] [Related]
45. Comparison of four procedures for separating apolipoprotein A- and apolipoprotein B-containing lipoproteins in plasma.
Puchois P; Luley C; Alaupovic P
Clin Chem; 1987 Sep; 33(9):1597-602. PubMed ID: 3113768
[TBL] [Abstract][Full Text] [Related]
46. Characterization of lipoprotein produced by the perfused rhesus monkey liver.
Jones LA; Teramoto T; Juhn DJ; Goldberg RB; Rubenstein AH; Getz GS
J Lipid Res; 1984 Apr; 25(4):319-35. PubMed ID: 6427376
[TBL] [Abstract][Full Text] [Related]
47. Apolipoprotein distribution in human lipoproteins separated by polyacrylamide gradient gel electrophoresis.
Vézina CA; Milne RW; Weech PK; Marcel YL
J Lipid Res; 1988 May; 29(5):573-85. PubMed ID: 3411236
[TBL] [Abstract][Full Text] [Related]
48. Lipid and apolipoprotein distribution as a function of density in equine plasma lipoprotein.
Le Goff D; Pastier D; Hannan Y; Petit E; Ayrault-Jarrier M; Nouvelot A
Comp Biochem Physiol B; 1989; 93(2):371-7. PubMed ID: 2776430
[TBL] [Abstract][Full Text] [Related]
49. In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase and apoB-containing lipoproteins.
Cheung MC; Wolf AC
J Lipid Res; 1989 Apr; 30(4):499-509. PubMed ID: 2502592
[TBL] [Abstract][Full Text] [Related]
50. Trans fatty acids alter the lipid composition and size of apoB-100-containing lipoproteins secreted by HepG2 cells.
Mitmesser SH; Carr TP
J Nutr Biochem; 2005 Mar; 16(3):178-83. PubMed ID: 15741053
[TBL] [Abstract][Full Text] [Related]
51. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
52. Apolipoprotein B-38.9 does not associate with apo[a] and forms two distinct HDL density particle populations that are larger than HDL.
Groenewegen WA; Averna MR; Pulai J; Krul ES; Schonfeld G
J Lipid Res; 1994 Jun; 35(6):1012-25. PubMed ID: 8077841
[TBL] [Abstract][Full Text] [Related]
53. Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content.
Khoo C; Campos H; Judge H; Sacks FM
J Lipid Res; 1999 Feb; 40(2):202-12. PubMed ID: 9925648
[TBL] [Abstract][Full Text] [Related]
54. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes.
Li Z; McNamara JR; Fruchart JC; Luc G; Bard JM; Ordovas JM; Wilson PW; Schaefer EJ
J Lipid Res; 1996 Sep; 37(9):1886-96. PubMed ID: 8895054
[TBL] [Abstract][Full Text] [Related]
55. Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney.
Tarugi P; Ballarini G; Pinotti B; Franchini A; Ottaviani E; Calandra S
J Lipid Res; 1998 Apr; 39(4):731-43. PubMed ID: 9555939
[TBL] [Abstract][Full Text] [Related]
56. Purification and characterization of low density lipoprotein containing apolipoprotein B-48 from the plasma of an apoE-deficient patient.
Hashimoto Y; Tsukamoto K; Teramoto T; Kurokawa K; Watanabe T
Clin Chim Acta; 1997 Mar; 259(1-2):109-16. PubMed ID: 9086298
[TBL] [Abstract][Full Text] [Related]
57. Characterization of lipoproteins produced by the human liver cell line, Hep G2, under defined conditions.
Thrift RN; Forte TM; Cahoon BE; Shore VG
J Lipid Res; 1986 Mar; 27(3):236-50. PubMed ID: 3016129
[TBL] [Abstract][Full Text] [Related]
58. Studies on the assembly of apolipoprotein B-100- and B-48-containing very low density lipoproteins in McA-RH7777 cells.
Borén J; Rustaeus S; Olofsson SO
J Biol Chem; 1994 Oct; 269(41):25879-88. PubMed ID: 7929292
[TBL] [Abstract][Full Text] [Related]
59. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure.
Kimak E; Solski J
Ren Fail; 2002 Jul; 24(4):485-92. PubMed ID: 12212828
[TBL] [Abstract][Full Text] [Related]
60. Characterization of apoA-I-containing lipoprotein subpopulations secreted by HepG2 cells.
Cheung MC; Lum KD; Brouillette CG; Bisgaier CL
J Lipid Res; 1989 Sep; 30(9):1429-36. PubMed ID: 2557373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
